Who Actually Needs a GLP-1
The decision to continue GLP-1 therapy should be individualised, weighing metabolic benefits against gastrointestinal tolerability and disease control
Along with an increased risk of death, pregnant women with obesity are at a higher risk of miscarriage, stillbirth, pre-eclampsia, gestational diabetes, and venous thromboembolism, compared with women of normal BMI (18.5 to 1.8 mg did not increase the glucose-lowering effect
Month 5 to 6 (2.4 mg): At full maintenance dose, weight loss commonly continues but may begin to slow as the body approaches a new set point
In healthy people with normal B levels, additional B has no effect on energy metabolism
Feb 13, 2026 Three hundred dollars a month